Previous 10 | Next 10 |
Venus Concept press release (NASDAQ:VERO): Q4 GAAP EPS of -$0.08 beats by $0.02. Revenue of $32.6M (+26.2% Y/Y) beats by $0.6M. Fiscal Year 2022 Revenue Guidance: The Company expects total revenue for the twelve months ending December 31, 2022 in the range of $126 million to $130 million...
TORONTO, March 28, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2021. Fourth Qua...
Venus Concept (NASDAQ:VERO) is scheduled to announce Q4 earnings results on Monday, March 28th, before market open. The consensus EPS Estimate is -$0.09 (+73.5% Y/Y) and the consensus Revenue Estimate is $32M (+23.9% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revision and ...
ADN, BITF, CASI, ITRM, JEF, MNMD, SAIC, VERO, XPEV For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open
TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will present at the Maxim Virtual Growth Conference, which is...
TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, ...
Arenberg Capital initiates coverage of InMode stock with hold rating prior to the company's FY21 earnings on February 10, 2022. We ran multiple approaches to determine the fair valuation of this high-growth medtech company. Our DCF indicates a fair valuation at the current price l...
TORONTO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2022 financial results will be released before the m...
TORONTO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (ȁ...
TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2021. ...
News, Short Squeeze, Breakout and More Instantly...
TORONTO, July 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2024 financial results will be released before the market o...
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the successful completion of its NEXThetics events held across several major cities in North America. NEXThetics events bring to...
TORONTO, June 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has entered a new strategic resurfacing and skin tightening device supply arrangement with Skin Laundry Holdings, ...